Pure Bioscience 

$0.069700
5
+$0.01+25.36% Monday 13:30

Statistics

Day High
0.0698
Day Low
0.0698
52W High
0.14
52W Low
0.04
Volume
175
Avg. Volume
29,950
Mkt Cap
9.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

16MarExpected
Q3 2022
Q1 2024
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q4 2025
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.01

Financials

-108.95%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.2MRevenue
-2.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PURE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.
Show more...
CEO
Mr. Robert F. Bartlett
Employees
12
Country
United States
ISIN
US74621T2096

Listings

0 Comments

Share your thoughts

FAQ

What is Pure Bioscience stock price today?
The current price of PURE is $0.07 USD — it has increased by +25.36% in the past 24 hours. Watch Pure Bioscience stock price performance more closely on the chart.
What is Pure Bioscience stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pure Bioscience stocks are traded under the ticker PURE.
Is Pure Bioscience stock price growing?
PURE stock has risen by +25.59% compared to the previous week, the month change is a -0.43% fall, over the last year Pure Bioscience has showed a -12.87% decrease.
What is Pure Bioscience market cap?
Today Pure Bioscience has the market capitalization of 9.06M
What were Pure Bioscience earnings last quarter?
PURE earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pure Bioscience revenue for the last year?
Pure Bioscience revenue for the last year amounts to 2.2M USD.
What is Pure Bioscience net income for the last year?
PURE net income for the last year is -2.4M USD.
How many employees does Pure Bioscience have?
As of July 07, 2026, the company has 12 employees.
In which sector is Pure Bioscience located?
Pure Bioscience operates in the Essentials sector.
When did Pure Bioscience complete a stock split?
The last stock split for Pure Bioscience was on August 15, 2012 with a ratio of 1:8.
Where is Pure Bioscience headquartered?
Pure Bioscience is headquartered in El Cajon, United States.